SCYNEXIS, Inc. Share Price & Technical Analysis
SCYX · $0.73 (+2.82%)
Healthcare / Drug Manufacturers - Specialty & Generic
$0.73
+2.82%
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the trea…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-22% return in May, 3% avg return in past 3 year May month.
37% return in 2026, -6% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 17% | 14% | 29% | 0% | -22% | – | – | – | – | – | – | – | 37% |
| 25 | -15% | -9% | 0% | 0% | -10% | -22% | 0% | 14% | 0% | -12% | 0% | -14% | -69% |
| 24 | -9% | -24% | -6% | 13% | 41% | -20% | 5% | -29% | 7% | -7% | 0% | -14% | -42% |
| 23 | 13% | -12% | 88% | 7% | -22% | 20% | 0% | 21% | -34% | -14% | -11% | 38% | 93% |
| 22 | -20% | -16% | -5% | -32% | -22% | -10% | 21% | 9% | -4% | -4% | 0% | -30% | -114% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$58.80M
P/E ratio
—
52W high
$1.31
52W low
$0.56
Volume
4,22,824
Beta
1.12
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is SCYNEXIS, Inc. share price today?
- SCYNEXIS, Inc. (SCYX) last traded around $0.73 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SCYX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SCYX. Download the app for real-time alerts.
- How can I analyze SCYNEXIS, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.